Transfer of manualized CBT for social phobia into clinical practice (SOPHO-PRAX): a study protocol for a cluster-randomized controlled trial

Trials

Jürgen Hoyer³  Jörg Wiltink¹  Ulrich Stangier²  Denise Ginzburg²  Eric Leibing⁴  Stephen Crawcour³ 

[1] Clinic of Psychosomatic Medicine and Psychotherapy, University Medical Center of the Johannes Gutenberg University of Mainz, Untere Zahlbacher Straße 8, 55131, Mainz, Germany;Institut für Psychologie - Klinische Psychologie und Psychotherapie, Goethe University Frankfurt, Varrentrappstr. 40-42, 60486, Frankfurt am Main, Germany;Clinical Psychology and Psychotherapy, Technische Universität/University of Technology Dresden, Institutsambulanz und Tagesklinik IAP-TUD GmbH, Hohe Straße 53, 01187, Dresden, Germany;Abteilung Psychosomatische Medizin und Psychotherapie Zentrum Psychosoziale Medizin, Georg-August University, von-Siebold-Str, 5, 37075, Göttingen, Germany

关键词: Outcome;    Treatment;    Dissemination;    Training;    Phase-IV research;    Remission;    Cognitive behavioral therapy;    Social phobia;   

Others  :  1095563
DOI  :  10.1186/1745-6215-13-70

 received in 2012-01-26, accepted in 2012-04-25,  发布年份 2012

【 摘 要 】

Background

Cognitive-behavioral therapy (CBT) is generally known to be efficacious in the treatment of social phobia when applied in RCTs, namely when the treatment manual is based on the Clark-Wells approach. However, little is known about the efficacy of manualized treatments in routine clinical practice (Phase IV of psychotherapy research). The present study (SOPHO-PRAX) is a continuation of a large multicenter randomized clinical trial (SOPHO-NET) and analyzes the extent to which additional training practitioners in manualized procedures enhances treatment effect.

Methods/design

Thirty-six private practitioners will be included in three treatment centers and randomly designated to either training in manualized CBT or no specific training. The treatment effects of the therapies conducted by both groups of therapists will be compared. A total of 162 patients (n = 116 completers; n = 58 per condition) will be enrolled. Liebowitz Social Anxiety Scale (LSAS) will serve as primary outcome measure. Remission from social phobia is defined as LSAS total ≤30 points. Data will be collected at treatment begin, after 8, 15, and 25 sessions (50 min each), at treatment completion, as well at 6 and 12 months post-treatment.

Discussion

The present CBT trial combines elements of randomized controlled trials and naturalistic studies in an innovative way. It will directly inform about the incremental effects of procedures established in a controlled trial into clinical practice. Study results are relevant to healthcare decisions and policy. They may serve to improve quality of treatment, and shorten the time frame between the development and widespread dissemination of effective methods, thereby reducing health cost expenditure.

The results of this study will not only inform about the degree to which the new methods lead to an improvement of treatment course and outcome, but also about whether the effects of routine psychotherapeutic treatment are comparable to those of the controlled, strictly manualized treatments of the SOPHO-NET study.

Trial registration

ClinicalTrials.gov identifier: NCT01388231. This study was funded by the German Federal Ministry of Education and Research (SOPHO-NET: BMBF 01GV0607; SOPHO-PRAX: BMBF 01GV1001).

【 授权许可】

   
2012 Crawcour et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

【 参考文献 】

• [1]American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders DSM-IV-TR Fourth Edition (Text Revision). Washington: APA; 2000.
• [2]Fehm L, Beesdo K, Jacobi F, Fiedler A: Social anxiety disorder above and below the diagnostic threshold: prevalence, comorbidity and impairment in the general population. Soc Psychiatry Psychiatr Epidemiol 2008, 43:257-265.
• [3]Ruscio AM, Brown TA, Chiu WT, Sareen J, Stein MB, Kessler RC: Social fears and social phobia in the United States: results from the National Comorbidity Survey Replication. Psychol Med 2008, 38:15-28.
• [4]Fehm L, Pelissolo A, Furmark T, Wittchen H-U: Size and burden of social phobia in Europe. Eur Neuropsychopharmacol 2005, 15:453-462.
• [5]Wittchen HU, Jacobi F: Die Versorgungssituation psychischer Störungen in Deutschland. Eine klinisch-epidemiologische Abschätzung anhand des Bundes-Gesundheitssurveys 1998. Bundesgesundheitsbl Gesundheitsforsch Gesundheitsschutz 2001, 44:993-1000.
• [6]Wittchen HU, Fehm L: Epidemiology and natural course of social fears and social phobia. Acta Psychiatr Scand 2003, 108(Suppl 1):4-18.
• [7]Beesdo K, Bittner A, Pine DS, Stein MB, Höfler M, Lieb R, Wittchen H-U: Incidence of social anxiety disorder and the consistent risk for secondary depression in the first three decades of life. Arch Gen Psychiatry 2007, 64:903-912.
• [8]DeWit DJ, Ogborne A, Offord DR, McDonald K: Antecedents of the risk of recovery from DSM-III social phobia. Psychol Med 1999, 29:569-582.
• [9]Keller MB: The lifelong course of social anxiety disorder: a clinical perspective. Acta Psychiatr Scand 2003, 108(Suppl 1):85-94.
• [10]Yonkers KA, Dyck IR, Keller MB: An eight-year longitudinal comparison of clinical course and characteristics of social phobia among men and women. Psychiatr Serv 2001, 52:637-643.
• [11]Beidel DC, Turner SM, Dancu CV: Physiological, cognitive, and behavioral aspects of social anxiety. Behav Res Ther 1985, 23:109-117.
• [12]Heimberg RG, Hope DA, Dodge CS, Becker RE: DSM-III-R subtypes of social phobia: comparison of generalized social phobics and public speaking phobics. J Nerv Ment Dis 1990, 178:172-179.
• [13]Herbert JD, Hope DA, Bellack AS: Validity of the distinction between generalized social phobia and avoidant personality disorder. J Abnorm Psychol 1992, 101:332-339.
• [14]Ludwig R, Lazarus P: Relationship between shyness in children and constricted cognitive control as measured by the Stroop Color-Word Test. J Consult Clin Psych 1983, 51:386-389.
• [15]Powers MB, Sigmarsson SR, Emmelkamp PMP: A meta-analytic review of psychological treatments for social anxiety disorder. Int J Cogn Ther 2008, 1:94-113.
• [16]Acarturk C, Cujpers P, van Straten A, de Graaf R: Psychological treatment of social anxiety disorder: a meta-analysis. Psychol Med 2009, 39:241-254.
• [17]Clark D, Wells A: A cognitive model of social phobia. In In Social phobia: Diagnosis, assessment, and treatment. Edited by Heimberg R, Liebowitz M, Hope D, Schneier F. New York: Guilford; 1995:69-93.
• [18]Clark DM, Ehlers A, McManus F, Hackmann A, Fennell M, Campbell H, Flower T, Davenport C, Louis B: Cognitive therapy versus Fluoxetine in generalized social phobia: a randomized placebo-controlled trial. J Consult Clin Psych 2003, 71:1058-1067.
• [19]Clark DM, Ehlers A, Hackman A, McManus F, Fennell M: Cognitive therapy versus exposure and applied relaxation in Social Phobia: a randomized controlled trial. J Consult Clin Psych 2006, 74:568-578.
• [20]Barlow DH: The dissemination and implementation of evidence-based psychological treatments – a review of current efforts. Am Psychol 2004, 59:869-878.
• [21]Leichsenring F, Hoyer J, Beutel M, Herpertz S, Hiller W, Irle E, Joraschky P, König HH, de Liz TM, Nolting B, Pöhlmann K, Salzer S, Schauenburg H, Stangier U, Strauss B, Subic-Wrana C, Vormfelde S, Weniger G, Willutzki U, Wiltink J, Leibing E: The Social Phobia Psychotherapy Research Network. The first multicenter randomized controlled trial of psychotherapy for social phobia: rationale, methods and patient characteristics. Psychother Psychosomat 2009, 78:35-41.
• [22]Stangier U: Clark DM, Ehlers A: Soziale Phobie. Hogrefe, Göttingen; 2006.
• [23]Stangier U, Ehlers A: Clark DM: Soziale Phobie. Hogrefe, Fortschritte der Psychotherapie. Göttingen; 2006.
• [24]Stangier U, Heidenreich T, Stangier U, Heidenreich T: Liebowitz Soziale Angst Skala. Internationale Skalen für Psychiatrie 5th edition. 2005.
• [25]Fydrich T: Soziale Phobie und Angstinventar (SPAI). Deutschsprachige Adaptation des "Social Phobia and Anxiety Inventory" von Turner und Beidel. Hogrefe, Göttingen; 2003.
• [26]Stangier U, Heidenreich T, Peitz M: Soziale Phobien. Weinheim: Beltz, Ein kognitiv-verhaltenstherapeutisches Behandlungsmanual; 2003.
• [27]Stangier U, Heidenreich T, Schermelleh-Engel K: Safety behaviors and social performance in patients with generalized social phobia. J CogPsychother 2006, 20:417-431.
• [28]Davidson JR, Potts NL, Richichi EA, Ford SM, Krishnan KR, Smith RD, Wilson W: The brief social phobia scale. J Clin Psychiat 1991, 52(Suppl 1):48-51.
• [29]Hautzinger M, Bailer M, Worall H: Keller, F: Das Beck Depressionsinventar. Bern: Huber; 1995.
• [30]von der Schulenburg JM G, Claes C, Greiner W, Uber A: Die deutsche Version des EuroQol-Fragebogens. Zeitschrift für Gesundheitswissenschaften 1998, 6:3-20.
• [31]Hoffmann SG, Kashdan B: The affective style questionnaire: development and psychometric properties. J Psychopathol Behav 2009, 32:255-263.
• [32]Bassler M, Potratz B, Krauthauser H: Der "Helping Alliance Questionaire" (HAQ) von Luborsky. Möglichkeiten zur Evaluation des therapeutischen Prozesses von stationärer Psychotherapie. Psychotherapeut 1995, 40:23-32.
• [33]Krampen G: Stundenbogen für die Allgemeine und Differentielle Einzelpsychotherapie. Göttingen: Hogrefe; 2002.
• [34]Borkovec TD, Nau SD: Credibility of analogue therapy rationales. J Behav Ther Exp Psy 1972, 3:257-260.
• [35]Holt CS, Heimberg RG: The reaction to treatment questionnaire: measuring treatment credibility and outcome expectancies. The Behavior Therapist 1990, 13:213-214.
• [36]Zaider TI, Heimberg RG, Fresco DM, Schneier FR, Liebowitz MR: Evaluation of the clinical global impression scale among individuals with social anxiety disorder. Psychol Med 2003, 33:611-622.
• [37]Wiltink J, Ruckes C, Haselbacher A, Canterino M, Leichsenring F, Joraschky P, Leweke F, Pöhlmann K, Beutel ME: Transfer of manualized Short Term Psychodynamic Psychotherapy (STPP) for social phobia into clinical practice: study protocol for a cluster-randomised controlled trial. Trials 2011, 12:142. BioMed Central Full Text
• [38]Roick C, Kilian R, Matschinger H, Bernert S, Mory C, Angermeyer MC: German adaptation of the client sociodemographic and service receipt inventory - an instrument for the cost of mental health care. Psychiatr Prax 2001, 28(Suppl 2):84-90.
• [39]Sholomskas DE, Syracuse-Siewert G, Rounsaville BJ, Ball SA, Nuro KF, Carroll KM: We don’t train in vain: A dissemination trial of three strategies of training clinicians in cognitive-behavioral therapy. J Consult Clin Psych 2005, 73:106-115.
• [40]Campbell MJ, Mollison J, Grimshaw JM: Cluster trials in implementation research: estimation of intracluster correlation coefficients and sample size. Stat Med 2001, 20:391-399.
• [41]Campbell MJ, Elbourne DR, Altman DG: CONSORT statement: extension to cluster randomised trials. BMJ 2004, 238:702-708.
• [42]Donner A, Klar N: Design and Analysis of Cluster Randomization Trials in Health Research. London: Arnold; 2000.
• [43]Stangier US, Heidenreich T, Peitz M, Lauterbach W, Clark DM: Cognitive therapy for social phobia: individual versus group treatment. Behav Res Ther 2003, 41:991-1007.
• [44]Elashoff JD: nQuery Advisor. Version 6.01 User’s Guide. Los Angeles, CA; 2005.
• [45]Stangier US, Schramm E, Heidenreich T, Berger M, Clark DM: Cognitive therapy vs interpersonal psychotherapy in social anxiety disorder - a randomized controlled trial. Arch Gen Psychiatry 2011, 68:692-700.
• [46]Wood AM, White IR, Hillson M, Carpenter J: Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes. Int J Epidemiol 2005, 34:89-99.
• [47]Campbell MK, Mollison J, Steen N, Grimshaw JM, Eccles M: Analysis of cluster randomized trials in primary care: a practical approach. Fam Pract 2000, 17:192-196.
• [48]Gaston JE, Abbott MJ, Rapee RM, Neary SA: Do empirically supported treatments generalize to private practice? A benchmark study of a cognitive-behavioural group treatment programme for social phobia. Br J Clin Psychol 2006, 45:33-48.
• [49]Dimeff LA, Koerner K, Woodcock EA, Beadnell B, Brown MZ, Skutch JM, Paves AP, Bazinet A, Harned MS: Which training method works best? A randomized controlled trial comparing three methods of training clinicians in dialectical behavior therapy skills. Behav Res Ther 2009, 47:921-930.
• [50]Thoma NC, McKay D, Gerber AJ, Milrod BL, Edwards AR, Kocsis JH: A quality-based review of randomized controlled trials of cognitive-behavioral therapy for depression: an assessment and metaregression. Am J Psychiatry 2012, 169:22-30.
• [51]Ost LG: Cognitive behavior therapy for anxiety disorders: 40 years of progress. Nord J Psychiatry 2008, 62(Suppl 1):5-10.
• [52]Shafran R, Clark DM, Fairburn CG, Arntz A, Barlow DH, Ehlers A, Freeston M, Garety PA, Hollon SD, Ost LG, Salkovskis PM, Williams JMG, Wilson GT: Mind the gap: Improving the dissemination of CBT. BRAT 2009, 47:902-909.
• [53]Beutel ME, Rasting M, Stuhr U, Rüger B, Leuzinger-Bohleber M: Assessing the impact of psychoanalyses and long-term psychoanalytic therapies on health care utilization and costs. Psychother Res 2004, 14:146-160.
• [54]Christensen E: Methodology of superiority vs. equivalence trials and non-inferiority trials. J Hepatol 2007, 46:947-954.
• [55]Bland JM, Altman DG: One and two sided tests of significance. BMJ 1994, 309:248.
• [56]Knottnerus JA, Bouter LM: The ethics of sample size: Two-sided testing and one-sided thinking. J ClinEpidemiol 2001, 54:109-111.